Viking Therapeutics, Inc. (VKTX)
32.33
-1.59
(-4.69%)
USD |
NASDAQ |
Mar 20, 16:00
32.91
+0.58
(+1.79%)
Pre-Market: 08:46
Viking Therapeutics EPS Diluted (Quarterly) : -1.383 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Eli Lilly & Co. | 7.024 |
| Amgen, Inc. | 2.455 |
| Pfizer Inc. | -0.2898 |
| Hims & Hers Health, Inc. | 0.0893 |
| Altimmune, Inc. | -0.2719 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -157.66M |
| Total Expenses (Quarterly) | 157.66M |
| Enterprise Value | 3.030B |
| Earnings Yield | -9.85% |
| Normalized Earnings Yield | -9.845 |